An AI algorithm significantly reduced false positives in lung cancer detection on CT scans, according to international multi-site research.
Key Details
- 1Study published in 'Radiology' evaluated an AI model for lung nodule assessment.
- 2AI was trained on over 16,000 nodules from the National Lung Screening Trial.
- 3Validation used CT datasets from three additional European screening trials.
- 4The algorithm was tested on data from more than 4,000 participants and nearly 8,000 nodules.
- 5Results showed the AI nearly halved the rate of false positives in lung cancer detection.
Why It Matters
Reducing false positives could decrease unnecessary procedures, lower healthcare costs, and reduce patient anxiety. Robust multi-site validation of AI models is crucial for their adoption in clinical lung cancer screening workflows.
Source
Health Imaging
Related News
•AuntMinnie
AI Tool Mirai Shows Robust Performance for Interval Breast Cancer Detection
The Mirai AI model significantly improves detection of interval breast cancers in negative screening mammograms.
•Radiology Business
AI Tool Predicts Interval Breast Cancer Risk from Negative Mammograms
AI can predict interval breast cancer risk up to three years after a negative mammogram.
•Radiology Business
AI Outperforms Radiologists in Predicting Lung Cancer Treatment Response
AI tools demonstrate higher accuracy than radiologists in predicting lung cancer treatment response from imaging studies.